Acurx Pharmaceuticals Statistics
Total Valuation
ACXP has a market cap or net worth of $5.06 million. The enterprise value is -$4.60 million.
| Market Cap | 5.06M |
| Enterprise Value | -4.60M |
Important Dates
The last earnings date was Thursday, November 12, 2026, before market open.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ACXP has 5.27 million shares outstanding. The number of shares has increased by 210.75% in one year.
| Current Share Class | 5.27M |
| Shares Outstanding | 5.27M |
| Shares Change (YoY) | +210.75% |
| Shares Change (QoQ) | +24.79% |
| Owned by Insiders (%) | 2.44% |
| Owned by Institutions (%) | 8.75% |
| Float | 5.14M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.77 |
| P/TBV Ratio | 0.69 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.45, with zero debt.
| Current Ratio | 3.45 |
| Quick Ratio | 3.24 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -147.47% and return on invested capital (ROIC) is -94.16%.
| Return on Equity (ROE) | -147.47% |
| Return on Assets (ROA) | -62.89% |
| Return on Invested Capital (ROIC) | -94.16% |
| Return on Capital Employed (ROCE) | -112.64% |
| Weighted Average Cost of Capital (WACC) | -7.22% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.02M |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -80.72% in the last 52 weeks. The beta is -2.09, so ACXP's price volatility has been lower than the market average.
| Beta (5Y) | -2.09 |
| 52-Week Price Change | -80.72% |
| 50-Day Moving Average | 1.22 |
| 200-Day Moving Average | 1.90 |
| Relative Strength Index (RSI) | 32.94 |
| Average Volume (20 Days) | 99,591 |
Short Selling Information
The latest short interest is 97,568, so 1.85% of the outstanding shares have been sold short.
| Short Interest | 97,568 |
| Short Previous Month | 90,789 |
| Short % of Shares Out | 1.85% |
| Short % of Float | 1.90% |
| Short Ratio (days to cover) | 1.35 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -8.27M |
| Pretax Income | -8.10M |
| Net Income | -8.10M |
| EBITDA | n/a |
| EBIT | -8.27M |
| Earnings Per Share (EPS) | -$2.24 |
Balance Sheet
The company has $9.65 million in cash and no debt, with a net cash position of $9.65 million or $1.83 per share.
| Cash & Cash Equivalents | 9.65M |
| Total Debt | n/a |
| Net Cash | 9.65M |
| Net Cash Per Share | $1.83 |
| Equity (Book Value) | 7.34M |
| Book Value Per Share | 1.25 |
| Working Capital | 7.34M |
Cash Flow
| Operating Cash Flow | -6.79M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -6.79M |
| FCF Per Share | -$1.29 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ACXP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -210.75% |
| Shareholder Yield | -210.75% |
| Earnings Yield | -233.05% |
| FCF Yield | -134.22% |
Analyst Forecast
The average price target for ACXP is $17.00, which is 1,670.83% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $17.00 |
| Price Target Difference | 1,670.83% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on August 5, 2025. It was a reverse split with a ratio of 1:20.
| Last Split Date | Aug 5, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |